These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9145219)

  • 1. Pharmacokinetic analysis of enterohepatic circulation of etodolac and effect of hepatic and renal injury on the pharmacokinetics.
    Ogiso T; Kitagawa T; Iwaki M; Tanino T
    Biol Pharm Bull; 1997 Apr; 20(4):405-10. PubMed ID: 9145219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute hepatic and renal failure on pharmacokinetics of flunixin meglumine in rats.
    Hwang YH; Yun HI
    Exp Anim; 2011; 60(2):187-91. PubMed ID: 21512275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary excretion and enterohepatic cycling of R- and S-flurbiprofen in the rat.
    Eeckhoudt SL; Evrard PA; Verbeeck RK
    Drug Metab Dispos; 1997 Apr; 25(4):428-30. PubMed ID: 9107541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etodolac clinical pharmacokinetics.
    Brocks DR; Jamali F
    Clin Pharmacokinet; 1994 Apr; 26(4):259-74. PubMed ID: 8013160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR; Jamali F
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic disposition of etodolac in rats, dogs, and man.
    Cayen MN; Kraml M; Ferdinandi ES; Greselin E; Dvornik D
    Drug Metab Rev; 1981; 12(2):339-62. PubMed ID: 6461537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic difference between S-(+)- and R-(-)-etodolac in rats.
    Shi JM; Lai SG; Xu CJ; Duan GL; Li D
    Acta Pharmacol Sin; 2004 Aug; 25(8):996-9. PubMed ID: 15301730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation.
    Kawakami J; Yamamura Y; Santa T; Kotaki H; Uchino K; Sawada Y; Iga T
    J Pharm Sci; 1993 Mar; 82(3):301-5. PubMed ID: 8450426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of etodolac enantiomers in the rat after administration of phenobarbital or cimetidine.
    Brocks DR; Jamali F
    Eur J Drug Metab Pharmacokinet; 1992; 17(4):293-9. PubMed ID: 1301359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moment analysis of stereoselective enterohepatic circulation and unidirectional chiral inversion of ketoprofen enantiomers in rat.
    Yasui H; Yamaoka K; Nakagawa T
    J Pharm Sci; 1996 Jun; 85(6):580-5. PubMed ID: 8773953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stereoselective pharmacokinetics of etodolac in young and elderly subjects, and after cholecystectomy.
    Brocks DR; Jamali F; Russell AS; Skeith KJ
    J Clin Pharmacol; 1992 Nov; 32(11):982-9. PubMed ID: 1474171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absorption and enterohepatic circulation of baicalin in rats.
    Xing J; Chen X; Zhong D
    Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of the phase II metabolites of the non steroidal anti-inflammatory drug etodolac in human urine.
    Berendes U; Blaschke G
    Enantiomer; 1996; 1(4-6):415-22. PubMed ID: 9676278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative continuous infusion method for analysis of enterohepatic circulation and biliary excretion of cefixime in the rat.
    Yasui H; Yamaoka K; Nakagawa T
    J Pharm Sci; 1994 Jun; 83(6):819-23. PubMed ID: 9120813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral bioequivalence: effect of absorption rate on racemic etodolac.
    Boni JR; Korth-Bradley JM; Richards LS; Chiang ST; Hicks DR; Benet LZ
    Clin Pharmacokinet; 2000 Dec; 39(6):459-69. PubMed ID: 11192477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enantioselective analysis of etodolac in human plasma by LC-MS/MS: Application to clinical pharmacokinetics.
    de Miranda Silva C; Rocha A; Tozatto E; da Silva LM; Donadi EA; Lanchote VL
    J Pharm Biomed Anal; 2016 Feb; 120():120-6. PubMed ID: 26723001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enterohepatic circulation on the pharmacokinetics of diflunisal in rats.
    Lin JH; Yeh KC; Duggan DE
    Drug Metab Dispos; 1985; 13(3):321-6. PubMed ID: 2861991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic study of the enterohepatic circulation of acetaminophen glucuronide in rats.
    Watari N; Hanawa M; Iwai M; Kaneniwa N
    J Pharmacobiodyn; 1984 Nov; 7(11):811-9. PubMed ID: 6530646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.
    Moriwaki T; Yasui H; Yamamoto A
    Pharm Res; 2004 Jun; 21(6):1055-64. PubMed ID: 15212172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis in the rat of 4-hydroxynonenal metabolites excreted in bile: evidence of enterohepatic circulation of these byproducts of lipid peroxidation.
    Laurent A; Alary J; Debrauwer L; Cravedi JP
    Chem Res Toxicol; 1999 Oct; 12(10):887-94. PubMed ID: 10525263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.